Skip to content
★ Sign in to follow
AL

Adrienne L. Graves

Board Director
Director
Total declarations
17
Companies
4
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€317k

Latest filing published 22 Apr 2026 for Opus Genetics, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

Adrienne L. Graves: trading record in brief

Adrienne L. Graves is a declared insider at 4 companies (board member); the most frequent names are Akorn Inc, IVERIC bio, Inc. and Ocular Therapeutix, Inc. The record holds 17 filings, for trades running from 12 September 2012 to 20 April 2026.

Every open-market trade on record is a sale: 1 sale worth €317k. Besides market trades, the filings include 12 share grants and 3 option exercises.

The newest entry dates from 22 April 2026: a share grant, in Opus Genetics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Adrienne L. Graves

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations